SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Shares Out (Diluted) Over TimeExpanding
Percentile Rank100
3Y CAGR+141.6%
5Y CAGR+86.7%
Year-over-Year Change
Weighted average diluted shares outstanding
3Y CAGR
+141.6%/yr
Annual compound
5Y CAGR
+86.7%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
22.7x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 61340193.00 | +562.3% |
| 2024 | 9262000.00 | +67.8% |
| 2023 | 5521000.00 | +26.9% |
| 2022 | 4352000.00 | +59.2% |
| 2021 | 2734000.00 | +1.2% |
| 2020 | 2701000.00 | -37.9% |
| 2019 | 4347000.00 | - |